Cardio Diagnostics (CDIO) Competitors $3.75 -0.04 (-1.06%) Closing price 03:49 PM EasternExtended Trading$3.80 +0.05 (+1.31%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. RLYB, ASBP, ENLV, FBLG, NNVC, ALVR, PASG, NEUP, PMN, and NAIIShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Rallybio (RLYB), Aspire Biopharma (ASBP), Enlivex Therapeutics (ENLV), FibroBiologics (FBLG), NanoViricides (NNVC), AlloVir (ALVR), Passage Bio (PASG), Neuphoria Therapeutics (NEUP), Promis Neurosciences (PMN), and Natural Alternatives International (NAII). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Rallybio Aspire Biopharma Enlivex Therapeutics FibroBiologics NanoViricides AlloVir Passage Bio Neuphoria Therapeutics Promis Neurosciences Natural Alternatives International Rallybio (NASDAQ:RLYB) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation. Which has more risk and volatility, RLYB or CDIO? Rallybio has a beta of -1.1, meaning that its stock price is 210% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 2.94, meaning that its stock price is 194% more volatile than the S&P 500. Do institutionals & insiders believe in RLYB or CDIO? 90.3% of Rallybio shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 8.7% of Rallybio shares are owned by insiders. Comparatively, 13.3% of Cardio Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is RLYB or CDIO more profitable? Rallybio has a net margin of -5,473.33% compared to Cardio Diagnostics' net margin of -30,465.10%. Rallybio's return on equity of -71.66% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Rallybio-5,473.33% -71.66% -65.06% Cardio Diagnostics -30,465.10%-72.78%-66.17% Do analysts recommend RLYB or CDIO? Rallybio presently has a consensus target price of $5.00, indicating a potential upside of 742.60%. Given Rallybio's stronger consensus rating and higher possible upside, analysts plainly believe Rallybio is more favorable than Cardio Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rallybio 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer RLYB or CDIO? In the previous week, Rallybio had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 2 mentions for Rallybio and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.91 beat Rallybio's score of 1.45 indicating that Cardio Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Rallybio Positive Cardio Diagnostics Very Positive Which has preferable earnings & valuation, RLYB or CDIO? Cardio Diagnostics has lower revenue, but higher earnings than Rallybio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRallybio$640K38.75-$57.78M-$0.94-0.63Cardio Diagnostics$40K165.00-$8.38MN/AN/A SummaryRallybio beats Cardio Diagnostics on 8 of the 13 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.60M$3.10B$5.74B$10.24BDividend YieldN/A2.32%5.69%4.59%P/E RatioN/A21.3874.9326.41Price / Sales165.00244.04457.2789.16Price / CashN/A44.4425.8129.91Price / Book0.539.6413.256.28Net Income-$8.38M-$53.20M$3.29B$270.38M7 Day Performance3.31%0.44%0.47%2.70%1 Month Performance3.31%4.26%4.60%5.99%1 Year Performance-58.14%9.43%73.42%25.94% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics1.4717 of 5 stars$3.75-1.1%N/A-57.6%$6.60M$40K0.001Positive NewsGap DownRLYBRallybio3.2736 of 5 stars$0.59-2.4%$5.00+741.6%-46.8%$25.43M$640K-0.6340Positive NewsShort Interest ↓Gap UpASBPAspire BiopharmaN/A$0.510.0%N/AN/A$25.35MN/A0.00N/APositive NewsGap UpENLVEnlivex Therapeutics2.5428 of 5 stars$1.04-1.9%$10.00+861.5%-31.8%$25.07MN/A-1.7970News CoverageAnalyst ForecastShort Interest ↑FBLGFibroBiologics3.3008 of 5 stars$0.57-0.9%$13.00+2,183.1%-83.3%$24.06MN/A-1.5810Analyst ForecastNNVCNanoViricides0.2164 of 5 stars$1.44-3.4%N/A-9.9%$23.95MN/A-2.0020Short Interest ↑ALVRAlloVirN/A$4.62-0.9%N/A-77.5%$23.30MN/A-0.23110Gap DownHigh Trading VolumePASGPassage Bio4.0208 of 5 stars$7.12-0.8%$75.67+962.9%-56.6%$22.82MN/A-0.39130Positive NewsNEUPNeuphoria Therapeutics2.5788 of 5 stars$12.99+9.3%$21.00+61.7%N/A$22.35M$10K0.00N/APMNPromis Neurosciences3.6673 of 5 stars$0.44+1.6%$4.33+891.6%-64.2%$22.28MN/A-2.085Short Interest ↓Gap DownNAIINatural Alternatives International1.6503 of 5 stars$3.41-5.3%N/A-43.6%$22.24M$125.48M-2.45290Positive NewsShort Interest ↓Gap DownHigh Trading Volume Related Companies and Tools Related Companies RLYB Competitors ASBP Competitors ENLV Competitors FBLG Competitors NNVC Competitors ALVR Competitors PASG Competitors NEUP Competitors PMN Competitors NAII Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDIO Stock Alerts